Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Pervinder Sagoo"'
Autor:
Cristiano Scottà, Marianna Esposito, Henrieta Fazekasova, Giorgia Fanelli, Francis C. Edozie, Niwa Ali, Fang Xiao, Mark Peakman, Behdad Afzali, Pervinder Sagoo, Robert I. Lechler, Giovanna Lombardi
Publikováno v:
Haematologica, Vol 98, Iss 8 (2013)
Adoptive transfer of ex vivo expanded CD4+CD25+FOXP3+ regulatory T cells is a successful therapy for autoimmune diseases and transplant rejection in experimental models. In man, equivalent manipulations in bone marrow transplant recipients appear saf
Externí odkaz:
https://doaj.org/article/ed6bd5a55ae64dfe92fe7066766dc3c7
Autor:
Richard Tavaré, Pervinder Sagoo, Gopal Varama, Yakup Tanriver, Alice Warely, Sandra S Diebold, Richard Southworth, Tobias Schaeffter, Robert I Lechler, Reza Razavi, Giovanna Lombardi, Gregory E D Mullen
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e19662 (2011)
Dendritic cells (DCs) generated in vitro to present tumour antigens have been injected in cancer patients to boost in vivo anti-tumour immune responses. This approach to cancer immunotherapy has had limited success. For anti-tumour therapy, delivery
Externí odkaz:
https://doaj.org/article/df50062fa02145d1b44b378b066decbf
Autor:
Pervinder Sagoo, H. Bobby Gaspar
Publikováno v:
Gene Therapy. 30:197-215
Hematopoietic stem cells (HSCs) are precursor cells that give rise to blood, immune and tissue-resident progeny in humans. Their position at the starting point of hematopoiesis offers a unique therapeutic opportunity to treat certain hematologic dise
Autor:
Pervinder, Sagoo, H Bobby, Gaspar
Publikováno v:
Gene therapy.
Hematopoietic stem cells (HSCs) are precursor cells that give rise to blood, immune and tissue-resident progeny in humans. Their position at the starting point of hematopoiesis offers a unique therapeutic opportunity to treat certain hematologic dise
Autor:
Robert I. Lechler, Lesley A. Smyth, John Leech, Pervinder Sagoo, Giovanna Lombardi, Niwa Ali, Ehsan Sharif-Paghaleh, Kavitha Sunassee, Gregory E. D. Mullen
Publikováno v:
European Journal of Immunology
DC vaccines have been used to induce tumour-specific cytotoxic T cells . However, this approach to cancer immunotherapy has had limited success. To be successful, injected DCs need to migrate to the LNs where they can stimulate effector T cells . We
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Béatrice Breart, Susanna Celli, David Michonneau, Pervinder Sagoo, Zacarias Garcia, Philippe Bousso
Publikováno v:
Immunity
Immunity, 2016, CellPress, 44 (1), p143-154. ⟨10.1016/j.immuni.2015.12.008⟩
Immunity, Elsevier, 2016, CellPress, 44 (1), p143-154. ⟨10.1016/j.immuni.2015.12.008⟩
Immunity, 2016, CellPress, 44 (1), p143-154. ⟨10.1016/j.immuni.2015.12.008⟩
Immunity, Elsevier, 2016, CellPress, 44 (1), p143-154. ⟨10.1016/j.immuni.2015.12.008⟩
International audience; Allogeneic hematopoietic stem cell transplantation (allo-HSCT), a curative treatment for hematologic malignancies relies on donor cytotoxic T lymphocyte (CTL)-mediated graft-versus-leukemia (GVL) effect. Major complications of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb94e9b006dd5ed6d23bf3f2ddca851e
https://hal-pasteur.archives-ouvertes.fr/pasteur-01296510/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-01296510/document
Autor:
Pervinder Sagoo, Yuen Tsang, Giovanna Lombardi, Robert I. Lechler, Linda Barber, Alistair Noble, Kulachelvy Ratnasothy
Publikováno v:
European Journal of Immunology. 42:3322-3333
Chronic graft-versus-host disease (cGVHD) is characterised by a complex etiology of both alloimmune- and autoimmune-mediated disease progression and pathology, and is consequently difficult to control. The therapeutic potential of regulatory T (Treg)
Autor:
Béatrice Breart, Matthew L. Albert, Fabrice Lemaître, David Michonneau, Philippe Bousso, Zacarias Garcia, Pervinder Sagoo, Yves Levy
Publikováno v:
Nature Medicine
Nature Medicine, 2015, 22 (1), pp.64-71. ⟨10.1038/nm.4016⟩
Nature Medicine, Nature Publishing Group, 2015, 22 (1), pp.64-71. ⟨10.1038/nm.4016⟩
Nature Medicine, 2015, 22 (1), pp.64-71. ⟨10.1038/nm.4016⟩
Nature Medicine, Nature Publishing Group, 2015, 22 (1), pp.64-71. ⟨10.1038/nm.4016⟩
International audience; The inflammasome is activated in response to a variety of pathogens and has an important role in shaping adaptive immunity, yet the spatiotemporal orchestration of inflammasome activation in vivo and the mechanisms by which it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dbdd67e421ab9ac25057d9b23f2367c
https://hal-pasteur.archives-ouvertes.fr/pasteur-01253201/file/BoussoNatMed2015.pdf
https://hal-pasteur.archives-ouvertes.fr/pasteur-01253201/file/BoussoNatMed2015.pdf
Publikováno v:
Kidney International Supplements
Induction of transplantation tolerance remains the ideal long-term clinical and logistic solution to the current challenges facing the management of renal allograft recipients. In this review, we describe the recent studies and advances made in ident